These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 6137957

  • 1. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL, Kemmer FW, Doi K, Vranic M.
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [Abstract] [Full Text] [Related]

  • 2. Importance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs.
    Perez G, Kemmer FW, Lickley HL, Vranic M.
    Am J Physiol; 1981 Oct; 241(4):E328-35. PubMed ID: 7032319
    [Abstract] [Full Text] [Related]

  • 3. Important role of glucagon during exercise in diabetic dogs.
    Wasserman DH, Lickley HL, Vranic M.
    J Appl Physiol (1985); 1985 Oct; 59(4):1272-81. PubMed ID: 2865245
    [Abstract] [Full Text] [Related]

  • 4. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G, Lickley L, Vranic M.
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [Abstract] [Full Text] [Related]

  • 5. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M, Kawamori R, Pek S, Kovacevic N, Wrenshall GA.
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [Abstract] [Full Text] [Related]

  • 6. Effects of selective insulin or glucagon deficiency on glucose turnover.
    Lickley HL, Ross GG, Vranic M.
    Am J Physiol; 1979 Mar; 236(3):E255-62. PubMed ID: 426056
    [Abstract] [Full Text] [Related]

  • 7. Effect of islet-activating protein (IAP), purified from the culture medium of Bordetella pertussis, on the secretion of immunoreactive insulin and glucagon in normal, alloxan-treated, and depancreatized dogs.
    Yoshida T, Nakamura Y, Nakano K, Kondo M.
    Diabetes; 1981 May; 30(5):430-4. PubMed ID: 6262169
    [No Abstract] [Full Text] [Related]

  • 8. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H, Wiesenthal SR, MacDonald PE, McCall RH, Tchipashvili V, Rashid S, Satkunarajah M, Irwin DM, Shi ZQ, Brubaker PL, Wheeler MB, Vranic M, Efendic S, Giacca A.
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [Abstract] [Full Text] [Related]

  • 9. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
    Kemmer FW, Lickley HL, Gray DE, Perez G, Vranic M.
    Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
    [Abstract] [Full Text] [Related]

  • 10. Effect of growth hormone on acute glucagon and insulin release.
    Sirek A, Vranic M, Sirek OV, Vigas M, Policova Z.
    Am J Physiol; 1979 Aug; 237(2):E107-12. PubMed ID: 380363
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H, Dobbs R, Unger RH.
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [Abstract] [Full Text] [Related]

  • 12. Importance of glucagon in the control of futile cycling as studied in alloxan-diabetic dogs.
    Lickley HL, Kemmer FW, el-Tayeb KM, Vranic M.
    Diabetologia; 1987 Mar; 30(3):175-82. PubMed ID: 2884159
    [Abstract] [Full Text] [Related]

  • 13. Glucoregulation in alloxan-diabetic dogs.
    Lussier B, Vranic M, Kovacevic N, Hetenyi G.
    Metabolism; 1986 Jan; 35(1):18-24. PubMed ID: 3510360
    [Abstract] [Full Text] [Related]

  • 14. Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.
    Wasserman DH, Lickley HL, Vranic M.
    J Clin Invest; 1984 Oct; 74(4):1404-13. PubMed ID: 6148356
    [Abstract] [Full Text] [Related]

  • 15. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H, Dobbs RE, Unger RH.
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [Abstract] [Full Text] [Related]

  • 16. Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs.
    Valverde I, Dobbs R, Unger RH.
    Metabolism; 1975 Sep; 24(9):1021-8. PubMed ID: 1152674
    [Abstract] [Full Text] [Related]

  • 17. Effect of Bordetella pertussis vaccine on glucagon secretion in normal and alloxan dogs.
    Nakamura Y, Yoshida T, Osumi T, Araki Y, Kondo M.
    Endocrinol Jpn; 1980 Oct; 27(5):585-91. PubMed ID: 7016512
    [Abstract] [Full Text] [Related]

  • 18. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS, Lickley L, Jokay M, Efendic S, Vranic M.
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [Abstract] [Full Text] [Related]

  • 19. The effect of insulin-induced hypoglycaemia on the secretion of glucagon and hepatic glucose production in pancreatectomized dogs.
    Lussier B, Hetenyi G.
    Can J Physiol Pharmacol; 1986 Nov; 64(11):1440-2. PubMed ID: 3539287
    [Abstract] [Full Text] [Related]

  • 20. Failure of somatostatin to decrease blood glucose by suppression of extrapancreatic glucagon in severely diabetic depancreatized dogs.
    Matsuyama T, Tanaka R, Shima K, Tarui S.
    Endocrinol Jpn; 1978 Dec; 25(6):529-32. PubMed ID: 751798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.